Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Jakrawadee Julamanee"'
Autor:
Smith Kungwankiattichai, Weerapat Owattanapanich, Thanawat Rattanathammethee, Ekarat Rattarittamrong, Chantiya Chanswangphuwana, Chantana Polprasert, Wasithep Limvorapitak, Supawee Saengboon, Pimjai Niparuck, Teeraya Puavilai, Jakrawadee Julamanee, Pirun Saelue, Chinadol Wanitpongpun, Kannadit Prayongratana, Chantarapa Sriswasdi, Chajchawan Nakhakes
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTIntroduction Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) with a unique clinical presentation and prognosis. This study aimed to investigate the epidemiology, clinical characteristics, treatments, a
Externí odkaz:
https://doaj.org/article/09b4fda50922456cb3e3a0c24e40292f
Autor:
Jirakrit Saetang, Surasak Sangkhathat, Nawaphat Jangphattananont, Wannakorn Khopanlert, Jakrawadee Julamanee, Varomyalin Tipmanee
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Peripheral T-cell lymphoma (PTCL) is a type of non-Hodgkin lymphoma that progresses aggressively with poor survival rate. CAR T cell targeting T-cell receptor β-chain constant domains 1 (TRBC1) of malignant T cells has been developed recent
Externí odkaz:
https://doaj.org/article/0287a3cfbae1442187367d52cecaec69
Autor:
Socheatraksmey Ung, Pongsakorn Choochuen, Wannakorn Khopanlert, Kajornkiat Maneechai, Surasak Sangkhathat, Seitaro Terakura, Jakrawadee Julamanee
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
CD19 chimeric antigen receptor (CAR) T-cells have demonstrated remarkable outcomes in B-cell malignancies. Recently, the novel CD19CAR-T cells incorporated with B-cell costimulatory molecules of CD79A/CD40 demonstrated superior antitumor activity in
Externí odkaz:
https://doaj.org/article/fe3dee24b473479fa270ca67a58db151
Autor:
Jirakrit Saetang, Phutthipong Sukkapat, Ajay Mittal, Jakrawadee Julamanee, Wannakorn Khopanlert, Kajornkiat Maneechai, Rasool Abdul Nazeer, Surasak Sangkhathat, Soottawat Benjakul
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1683 (2023)
Chitooligosaccharide (COS) and gallic acid (GA) are natural compounds with anti-cancer properties, and their conjugate (COS–GA) has several biological activities. Herein, the anti-cancer activity of COS–GA in SW620 colon cancer cells was investig
Externí odkaz:
https://doaj.org/article/a2ea44d43c3a42a887531d7b6dac503c
Autor:
Toshiyasu Sakai, Seitaro Terakura, Kotaro Miyao, Shingo Okuno, Yoshitaka Adachi, Koji Umemura, Jakrawadee Julamanee, Keisuke Watanabe, Hiroshi Hamana, Hiroyuki Kishi, Judith Leitner, Peter Steinberger, Tetsuya Nishida, Makoto Murata, Hitoshi Kiyoi
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 613-622 (2020)
An artificial T cell adaptor molecule (ATAM) was generated to improve persistence of T cell receptor (TCR) gene-transduced T (TCR-T) cells compared to such persistence in a preceding study. ATAMs are gene-modified CD3ζ with the intracellular domain
Externí odkaz:
https://doaj.org/article/36662890f77a4d52a461678b98df3b75
Autor:
Daisuke Koyama, Makoto Murata, Ryo Hanajiri, Shingo Okuno, Sonoko Kamoshita, Jakrawadee Julamanee, Erina Takagi, Daiki Hirano, Kotaro Miyao, Reona Sakemura, Tatsunori Goto, Fumihiko Hayakawa, Aika Seto, Yukiyasu Ozawa, Koichi Miyamura, Seitaro Terakura, Tetsuya Nishida, Hitoshi Kiyoi
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0185213 (2017)
Regenerating islet-derived protein 3 alpha (REG3A) is a biomarker of lower gastrointestinal graft-versus-host disease (GVHD); however, the biological role of REG3A in the pathophysiology of GVHD is not understood. Here, we examined the association be
Externí odkaz:
https://doaj.org/article/e238b7407fde42068b4d12ef57c9b8c6
Autor:
Benjakul, Jirakrit Saetang, Phutthipong Sukkapat, Ajay Mittal, Jakrawadee Julamanee, Wannakorn Khopanlert, Kajornkiat Maneechai, Rasool Abdul Nazeer, Surasak Sangkhathat, Soottawat
Publikováno v:
Biomedicines; Volume 11; Issue 6; Pages: 1683
Chitooligosaccharide (COS) and gallic acid (GA) are natural compounds with anti-cancer properties, and their conjugate (COS–GA) has several biological activities. Herein, the anti-cancer activity of COS–GA in SW620 colon cancer cells was investig
Autor:
Thanawat Rattanathammethee, Lalita Norasetthada, Udomsak Bunworasate, Kitsada Wudhikarn, Jakrawadee Julamanee, Panarat Noiperm, Theerin Lanamtieng, Pisa Phiphitaporn, Manassamon Navinpipat, Piyapong Kanya, Dusit Jit-ueakul, Somchai Wongkhantee, Thanongsak Suwannathen, Juthatip Chaloemwong, Peerapon Wong, Nisa Makruasi, Archrob Khuhapinant, Kannadit Prayongratana, Pimjai Niparuck, Nonglak Kanitsap, Tawatchai Suwanban, Tanin Intragumtornchai
Publikováno v:
Annals of Hematology.
Autor:
Hitoshi Kiyoi, Makoto Murata, Tetsuya Nishida, Ryo Hanajiri, Tatsunori Goto, Daisuke Koyama, Kotaro Miyao, Erina Takagi, Jakrawadee Julamanee, Keisuke Watanabe, Seitaro Terakura, Reona Sakemura
pRetroX-TetOne vector sequence with CD19CAR and tEGFR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b2d9a27fc6424b85af595834e24ae11
https://doi.org/10.1158/2326-6066.22538173.v1
https://doi.org/10.1158/2326-6066.22538173.v1
Autor:
Hitoshi Kiyoi, Makoto Murata, Tetsuya Nishida, Ryo Hanajiri, Tatsunori Goto, Daisuke Koyama, Kotaro Miyao, Erina Takagi, Jakrawadee Julamanee, Keisuke Watanabe, Seitaro Terakura, Reona Sakemura
T cells genetically modified with a CD19 chimeric antigen receptor (CD19CAR) are remarkably effective against B-cell malignancies in clinical trials. However, major concerns remain regarding toxicities, such as hypogammaglobulinemia, due to B-cell ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86944350ed2ff9652e9af402617a1eb1
https://doi.org/10.1158/2326-6066.c.6548698.v1
https://doi.org/10.1158/2326-6066.c.6548698.v1